John Paulson Paulson & Co
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$15.6M |
| 2 |
THM
International Tower Hill Mines
THM
|
+$3.63M |
| 3 |
TCO
Taubman Centers Inc.
TCO
|
+$3.43M |
| 4 |
SSR Mining
SSRM
|
+$3.24M |
| 5 |
Lear
LEA
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$35.5M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$13.8M |
| 3 |
Qiagen
QGEN
|
+$7.89M |
| 4 |
TIM SA
TIMB
|
+$3.52M |
| 5 |
Takeda Pharmaceutical
TAK
|
+$3.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.8% |
| 2 | Materials | 24.24% |
| 3 | Communication Services | 9.22% |
| 4 | Financials | 8.04% |
| 5 | Consumer Discretionary | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $520M | 16.2% |
6,691,439
-200,000
| -3% | -$13.8M |
|
2
Bausch Health
BHC
$2.41B
| $402M | 12.52% |
25,839,035
| – | – |
|
3
SPDR Gold Trust
GLD
$152B
| $336M | 10.46% |
1,894,252
| – | – |
|
4
NovaGold Resources
NG
$3.83B
| $264M | 8.24% |
22,226,300
| – | – |
|
|
AAMI
5
Acadian Asset Management
AAMI
$3.28B
| $258M | 8.04% |
20,000,552
| – | – |
|
|
6
Takeda Pharmaceutical
TAK
$58.1B
| $202M | 6.28% |
11,295,846
-191,059
| -2% | -$3.48M |
|
7
AngloGold Ashanti
AU
$61.3B
| $184M | 5.73% |
6,974,331
| – | – |
|
8
Viatris
VTRS
$18.7B
| $170M | 5.31% |
11,478,260
| – | – |
|
|
DISCK
9
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $135M | 4.22% |
6,902,805
| – | – |
|
|
DISH
10
DELISTED
DISH Network Corp.
DISH
| $105M | 3.28% |
3,620,750
| – | – |
|
|
THM
11
International Tower Hill Mines
THM
$735M
| $82.4M | 2.57% |
61,930,724
+2,337,410
| +4% | +$3.63M |
|
12
Pacira BioSciences
PCRX
$983M
| $75.5M | 2.35% |
1,255,608
-34,333
| -3% | -$1.99M |
|
|
KL
13
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $73.1M | 2.28% |
1,502,853
| – | – |
|
|
TIF
14
DELISTED
Tiffany & Co.
TIF
| $68.5M | 2.14% |
591,552
-12,248
| -2% | -$1.49M |
|
|
ENDP
15
DELISTED
Endo International plc
ENDP
| $47.8M | 1.49% |
14,497,569
+4,870,669
| +51% | +$15.6M |
|
|
PARA
16
DELISTED
Paramount Global Class B
PARA
| $44M | 1.37% |
1,569,920
| – | – |
|
|
B
17
Barrick Mining
B
$78.3B
| $43.5M | 1.36% |
1,546,772
+36
| +0% | +$1.02K |
|
|
PVG
18
DELISTED
PRETIUM RESOURCES INC.
PVG
| $30.8M | 0.96% |
2,400,000
| – | – |
|
19
Equinox Gold
EQX
$15.8B
| $29.3M | 0.91% |
2,500,000
| – | – |
|
|
TMQ
20
Trilogy Metals
TMQ
$684M
| $25.6M | 0.8% |
14,326,996
| – | – |
|
|
21
SSR Mining
SSRM
$7.7B
| $24.5M | 0.76% |
1,310,242
+152,042
| +13% | +$3.24M |
|
|
22
Qiagen
QGEN
$9.1B
| $20.8M | 0.65% |
377,222
-152,115
| -29% | -$7.89M |
|
|
OSG
23
DELISTED
Overseas Shipholding Group Inc.
OSG
| $13.5M | 0.42% |
6,300,000
| – | – |
|
|
SA
24
Seabridge Gold
SA
$3.25B
| $13.1M | 0.41% |
700,000
| – | – |
|
|
TCO
25
DELISTED
Taubman Centers Inc.
TCO
| $13M | 0.41% |
391,886
+91,886
| +31% | +$3.43M |
|
Similar funds
John Paulson's Q3 2020 Portfolio in Review
As of Q3 2020, John Paulson held 32 positions worth $3.21B, up 2.5% from $3.13B the previous quarter. Its ten largest holdings account for 80% of the portfolio.
John Paulson's Q3 2020 filing shows 2 new, 5 increased, 6 reduced and 1 closed positions. Its largest new stake was Lear: 10,103 shares worth $1.1M. The largest sale was TD Ameritrade Holding Corp, an estimated $35.5M.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 44% a quarter earlier, followed by Materials and Communication Services.
- John Paulson's largest Q3 2020 buy was Lear: 10,103 shares worth $1.1M.
- John Paulson added most to Endo International plc in Q3 2020, an estimated $15.6M increase.
- John Paulson's biggest Q3 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $13.8M.
- John Paulson fully exited TD Ameritrade Holding Corp in Q3 2020, selling an estimated $35.5M.
- John Paulson's ten largest holdings make up 80% of its $3.21B portfolio in Q3 2020.
- John Paulson opened 2 new positions and closed 1 in Q3 2020.
- John Paulson's portfolio value rose 2.5% quarter-over-quarter to $3.21B.
Based on Paulson & Co's 13F filing for Q3 2020, filed 16 Nov 2020.